The Precision Peptide Company Inc. recorded three insider acquisitions during the recent period. Director Pratapvir Sandhu executed these purchases, totaling 385,000 shares. These transactions represent a cumulative investment of 166,725 CAD. No divestments occurred, reflecting a singular focus on increasing equity stakes by this board member.